Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors

NCT06206681 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT06206681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06206681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Lead sponsor
Sun Yat-sen University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2022
Completion date
September 1, 2025
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eyelid tumor, keratosis, pigmented nevi, xanthelasma palpebrarum